Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Agren

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Lakartidningen|January 16, 2008
["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit]Håkan Wallén, Anna Agren, Michael Nekludov
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activityAnna Agren, Björn Wiman, Sam Schulman
Anesthesia and Analgesia|November 19, 2014
In responseAnna Agren, Agneta Wikman, Anders Ostlund, et al.
Thrombosis Research|January 21, 2012
A case series of five episodes of massive LMWH non-fatal self-induced overdose in a single patientJacob Odeberg, Anders Carlsson, Caroline Hällsjö-Sander, et al.
Anesthesia and Analgesia|May 1, 2014
TEG® functional fibrinogen analysis may overestimate fibrinogen levelsAnna Agren, Agneta Taune Wikman, Anders Ostlund, et al.
Thrombosis Research|August 3, 2011
Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathyAmmar Majeed, Anna Eelde, Anna Agren, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2025
Influence of bariatric surgery on endothelial and glycocalyx biomarkers in obesity and type 2 diabetesMaja Andersson, Anna Agren, Peter Henriksson, et al.
Blood Transfusion = Trasfusione Del Sangue|June 25, 2014
In vitro combinations of red blood cell, plasma and platelet components evaluated by thromboelastographyAnna Agren, Gustaf Edgren, Malin Kardell, et al.
Diabetes Care|April 25, 2014
Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetesAnna Agren, Gun Jörneskog, Graciela Elgue, et al.
Diabetes Care|October 25, 2014
Response to comment on Ågren et al. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes. Diabetes care 2014;37:2007-2014Anna Agren, Gun Jörneskog, Graciela Elgue, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Lakartidningen|January 16, 2008
["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit]Håkan Wallén, Anna Agren, Michael Nekludov
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activityAnna Agren, Björn Wiman, Sam Schulman
Anesthesia and Analgesia|November 19, 2014
In responseAnna Agren, Agneta Wikman, Anders Ostlund, et al.
Thrombosis Research|January 21, 2012
A case series of five episodes of massive LMWH non-fatal self-induced overdose in a single patientJacob Odeberg, Anders Carlsson, Caroline Hällsjö-Sander, et al.
Anesthesia and Analgesia|May 1, 2014
TEG® functional fibrinogen analysis may overestimate fibrinogen levelsAnna Agren, Agneta Taune Wikman, Anders Ostlund, et al.
Thrombosis Research|August 3, 2011
Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathyAmmar Majeed, Anna Eelde, Anna Agren, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2025
Influence of bariatric surgery on endothelial and glycocalyx biomarkers in obesity and type 2 diabetesMaja Andersson, Anna Agren, Peter Henriksson, et al.
Blood Transfusion = Trasfusione Del Sangue|June 25, 2014
In vitro combinations of red blood cell, plasma and platelet components evaluated by thromboelastographyAnna Agren, Gustaf Edgren, Malin Kardell, et al.
Diabetes Care|April 25, 2014
Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetesAnna Agren, Gun Jörneskog, Graciela Elgue, et al.
Diabetes Care|October 25, 2014
Response to comment on Ågren et al. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes. Diabetes care 2014;37:2007-2014Anna Agren, Gun Jörneskog, Graciela Elgue, et al.
Pageof 2